+27 (0) 11 084 4982
info@ezintsha.org
facebook logo
X logo icon
Linkedin Logo
Instagram Icon logo
Youtube Icon logo
iHEART-SA
  • About
    • Vision and Mission
    • Our Strategic Approach
    • Our History
    • Leadership
    • Partners and Donors
  • Focus Area
  • Projects
    • Current Projects
    • Closed Projects
  • Information Hub
    • Publications
    • Latest News
    • Policy and Guidelines
  • Careers
  • Events
    • Past Events
    • Upcoming Events
  • Contact Us

Practice of the Future Conference: 16 September 2023, Boksburg, Johannesbug

21 July 2023
Ezintsha Latest News
Practice of the Future Conference Event Details Date: 16 September 2023 Time: 08:00am – 17:00pm Venue: Birchwood Hotel & OR Tambo Conference Centre, 44 Viewpoint…
Read More

IAS Conference on HIV Science: 23 – 26 July 2023 Brisbane, Australia

17 February 2023
Ezintsha Latest News
IAS Conference on HIV Science IAS 2023, the 12th IAS Conference on HIV Science, will take place in Brisbane, Australia, and virtually from 23 to…
Read More

Interest Conference: 9 – 12 May 2023 Maputo, Mozambique

17 February 2023
Ezintsha Latest News
INTEREST Conference 2023 The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis,…
Read More

Exploratory Study of Four Repurposed Anti-Infective Drug Regimens

23 January 2023
2023 Publications
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.…
Read More

Clinical Infectious Diseases Brief Report

23 January 2023
2023 Publications
World Health Organization (WHO) guidelines for HIV treatment currently recommend tenofovir disoproxil fumarate (TDF) with either lamivudine (3TC) or emtricitabine (FTC) plus dolutegravir (DTG) as…
Read More

The National Strategic Plan

15 January 2023
2023 Publications
What is the draft NSP 2023-2028? The NSP 2017-2022 has run its course and we are developing a new plan. Now we invite you to…
Read More

2023 HIV Vaccine Science Academy

15 January 2023
2023 Publications
Apply now: 2023 HIV Vaccine Science Academy Are you an early- to mid-career HIV investigator or clinical scientist? Are you affiliated with or working in…
Read More

Call for Applications Infectious Diseases Workshop: 23 – 24 May 2023 Berlin, Germany

26 November 2022
Ezintsha Latest News
The Academy of Science of South Africa (ASSAf) and the German National Academy of Sciences (Leopoldina) are jointly hosting a workshop on “Infectious Diseases beyond…
Read More
Previous 1 2

Search

Recent News

  • DOR/ISL 100 mg/0.25 mg QD in HIV-1 antiretroviral treatment naive
  • Follow-up of Participants Who Received DOR/ISL (100 mg/0.75 mg)
  • Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
  • A Phase 3 trial to assess efficacy and safety of M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered to adolescents and adults
  • This is an interventional, randomised, double-blind, placebo-controlled, two-armed, parallel-group, multicentre, multinational clinical study

Categories

Archive

Office Hours

Monday to Friday: 8:00AM to 4:30PM
Saturdays: Closed
Sundays: Closed

Follow Us

Contact Us

32 Princess of Wales Terrace, Parktown, Johannesburg, 2193
+27 (0) 11 084 4982
+27 (0) 82 618 7851
info@ezintsha.org

Upcoming Events

Know what’s happening at Ezintsha, here

© Ezintsha (Pty) Ltd – All Rights Reserved | Designed by Cognite Marketing
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.